Knowledge of Hereditary Prostate Cancer Among High-Risk African American Men

Sally P. Weinrich

Srinivasan Vijayakumar

Isaac J. Powell

Julie Priest

Cathy Atkinson Hamner

Laryssa McCloud

Curtis Pettaway

hereditary risk, African American, male
ONF 2007, 34(4), 854-860. DOI: 10.1188/07.ONF.854-860

Purpose/Objectives: To measure knowledge of hereditary prostate cancer in a group of high-risk African American men.

Design: Cross-sectional, correlational pilot study.

Setting: Four geographic sites: Detroit, MI; Houston, TX; Chicago, IL; and Columbia, SC.

Sample: 79 men enrolled in the African American Hereditary Prostate Cancer Study.

Methods: Telephone interviews.

Main Research Variables: Knowledge of hereditary prostate cancer.

Findings: Knowledge of hereditary prostate cancer was low.

Conclusions: The high percentage of incorrect responses on questions that measure genetic testing, prevention, and risk based on a positive family history highlights educational needs.

Implications for Nursing: A critical need exists for nurses to educate high-risk African American men about hereditary prostate cancer.

Jump to a section


    American Cancer Society. (2007). Cancer facts and figures for African Americans 2007-2008. Retrieved June 18, 2007, from
    Baffoe-Bonnie, A.B., Kittles, R.A., Gillanders, E., Ou, L., George, A., Robbins, C., et al. (2007). Genome-wide linkage of 77 families from the African American Hereditary Prostate Cancer Study (AAHPC). Prostate, 67(1), 22-31.
    Balbay, M.D., Pettaway, C.A., Kuniyasu, H., Inoue, K., Ramirez, E., Li, E., et al. (1999). Highly metastatic human prostate cancer growing within the prostate of athymic mice over expresses vascular endothelial growth factor. Clinical Cancer Research, 5, 783-789.
    Berry, R., Schroeder, J.J., French, A.J., McDonnell, S.K., Peterson, B.J., Cunningham, J.M., et al. (2000). Evidence for a prostate cancer-susceptibility locus on chromosome 20. American Journal of Human Genetics, 67, 82-91.
    Berthon, P., Valeri, A., Cohen-Akenine, A., Drelon, E., Paiss, T., Wohr, G., et al. (1998). Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. American Journal of Human Genetics, 62, 1416-1424.
    Bock, C.H., Cunningham, J.M., McDonnell, S.K., Schaid, D.J., Peterson, B.J., Pavlic, R.J., et al. (2001). Analysis of the prostate cancer-susceptibility locus HPC20 in 172 families affected by prostate cancer. American Journal of Human Genetics, 68, 795-801.
    Bratt, O., Damber, J.E., Emanuelsson, M., Kristoffersson, U., Lundgren, R., Olsson, H., et al. (2000). Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. European Journal of Cancer, 36, 235-241.
    Bratt, O., Kristoffersson, U., Lundgren, R., & Olsson, H. (1997). Sons of men with prostate cancer: Their attitudes regarding possible inheritance of prostate cancer, screening, and genetic testing. Urology, 50, 360-365.
    Carmines, E.G., & Zeller, R.A. (1979). Reliability and validity assessment. Beverly Hills, CA: Sage.
    Carpten, J., Nupponen, N., Isaacs, S., Sood, R., Robbins, C., Xu, J., et al. (2002). Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nature Genetics, 30, 181-184.
    Chang, B., Zheng, S.L., Isaacs, S.D., Wiley, K.E., Carpten, J.D., Hawkins, G.A., et al. (2001). Linkage and association of CYP17 gene in hereditary and sporadic prostate cancer. International Journal of Cancer, 95, 354-359.
    Chang, B.L., Zheng, S.L., Hawkins, G.A., Isaacs, S.D., Wiley, K.E., Turner, A., et al. (2002). Joint effect of HSD3B1 and HSD3B2 genes is associated with hereditary and sporadic prostate cancer susceptibility. Cancer Research, 62, 1784-1789.
    Cooney, K.A. (1998). Hereditary prostate cancer in African-American families. Seminars in Urologic Oncology, 16, 202-206.
    Cooney, K.A., McCarthy, J.D., Lange, E., Huang, L., Miesfeldt, S., Montie, J.E., et al. (1997). Prostate cancer susceptibility locus on chromosome 1q: A confirmatory study. Journal of the National Cancer Institute, 89, 955-959.
    DeVillis, R. (1991). Scale development: Theory and applications. Newbury Park, CA: Sage.
    Gibbs, M., Stanford, J.L., Jarvik, G.P., Janer, M., Badzioch, M., Peters, M.A., et al. (2000). A genomic scan of families with prostate cancer identifies multiple regions of interest. American Journal of Human Genetics, 67, 100-109.
    Goode, E.L., Stanford, J.L., Chakrabarti, L., Gibbs, M., Kolb, S., McIndoe, R.A., et al. (2000). Linkage analysis of 150 high-risk prostate cancer families at 1q24-25. Genetic Epidemiology, 18, 251-275.
    Goode, E.L., Stanford, J.L., Peters, M.A., Janer, M., Gibbs, M., Kolb, S., et al. (2001). Clinical characteristics of prostate cancer in an analysis of linkage to four putative susceptibility loci. Clinical Cancer Research, 7, 2739-2749.
    Gronberg, H., Ahman, A.K., Emanuelsson, M., Bergh, A., Damber, J.E., & Borg, A. (2001). BRCA2 mutation in a family with hereditary prostate cancer. Genes, Chromosomes, and Cancer, 30, 299-301.
    Gronberg, H., Isaacs, S.D., Smith, J.R., Carpten, J.D., Bova, G.S., Freije, D., et al. (1997). Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus. JAMA, 278, 1251-1255.
    Gronberg, H., Smith, J., Emanuelsson, M., Jonsson, B.A., Bergh, A., Carpten, J., et al. (1999). In Swedish families with hereditary prostate cancer, linkage to the HPC1 locus on chromosome 1q24-25 is restricted to families with early-onset prostate cancer. American Journal of Human Genetics, 65, 134-140.
    Gronberg, H., Xu, J., Smith, J.R., Carpten, J.D., Isaacs, S.D., Freije, D., et al. (1997). Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1. Cancer Research, 57, 4707-4709.
    Hsieh, C.L., Oakley-Girvan, I., Gallagher, R.P., Wu, A.H., Kolonel, L.N., Teh, C.Z., et al. (1997). Re: Prostate cancer susceptibility locus on chromosome 1q: A confirmatory study [Letter to the editor.]. Journal of the National Cancer Institute, 89, 1893-1894.
    Jenkins, J., Grady, P.A., & Collins, F.S. (2005). Nurses and the genomic revolution. Journal of Nursing Scholarship, 37, 98-101.
    Karayi, M.K., Neal, D.E., & Markham, A.F. (2000). Current status of linkage studies in hereditary prostate cancer. BJU International, 86, 659-669.
    Kittles, R.A., Baffoe-Bonnie, A.B., Moses, T.Y., Robbins, C.M., Ahaghotu, C., Huusko, P., et al. (2006). A common nonsense mutation in EphB2 is associated with prostate cancer risk in African American men with a positive family history. Journal of Medical Genetics, 43, 507-511.
    Lange, E.M., Chen, H., Brierley, K., Livermore, H., Wojno, K.J., Langefeld, C.D., et al. (2000). The polymorphic exon 1 androgen receptor CAG repeat in men with a potential inherited predisposition to prostate cancer. Cancer Epidemiology, Biomarkers, and Prevention, 9, 439-442.
    Lehrer, S., McCurdy, L.D., Stock, R.G., Kornreich, R., Stone, N.N., & Eng, C. (2000). Body mass, age, and the APC I1307K allele in Ashkenazi Jewish prostate cancer patients. Cancer Genetics and Cytogenetics, 122, 131-133.
    Miesfeldt, S., Jones, S.M., Cohn, W., Lippert, M., Haden, K., Turner, B.L., et al. (2000). Men's attitudes regarding genetic testing for hereditary prostate cancer risk. Urology, 55, 46-50.
    National Cancer Institute. (2006a). Genetics of prostate cancer. Retrieved September 22, 2006, from
    National Cancer Institute. (2006b). Prostate cancer. Retrieved November 13, 2006, from
    Nwosu, V., Carpten, J., Trent, J.M., & Sheridan, R. (2001). Heterogeneity of genetic alterations in prostate cancer: Evidence of the complex nature of the disease. Human Molecular Genetics, 10, 2313-2318.
    O'Connor, A.M. (1995). Validation of a decisional conflict scale. Medical Decision Making, 15(1), 25-30.
    O'Connor, A.M., Drake, E.R., Fiset, V., Graham, I.D., Laupacis, A., & Tugwell, P. (1999). The Ottawa patient decision aids. Effective Clinical Practice, 2, 163-170.
    O'Connor, A.M., Fiset, V., DeGrasse, C., Graham, I.D., Evans, W., Stacey, D., et al. (1999). Decision aids for patients considering options affecting cancer outcomes: Evidence of efficacy and policy implications. Journal of the National Cancer Institute Monographs, 25, 67-80.
    O'Connor, A.M., & Jacobsen, M.J. (1998). Decisional conflict: Assessing and supporting patients experiencing uncertainty about decisions affecting their health. Unpublished manuscript.
    O'Connor, A.M., Rostom, A., Fiset, V., Tetroe, J., Entwistle, V., Llewellyn-Thomas, H., et al. (1999). Decision aids for patients facing health treatment or screening decisions: Systematic review. BMJ, 319, 731-734.
    O'Connor, A.M., Stacey, D., Entwistle, V., Llewellyn-Thomas, H., Rovner, D., Holmes-Rovner, M., et al. (2004). Decision aids for people facing health treatment or screening decisions. Cochrane Database of Systematic Reviews, 2, CD001431.
    O'Connor, A.M., Tugwell, P., Wells, G.A., Elmslie, T., Jolly, E., Hollingworth, G., et al. (1998a). A decision aid for women considering hormone therapy after menopause: Decision support framework and evaluation. Patient Education and Counseling, 33(3), 267-279.
    O'Connor, A.M., Tugwell, P., Wells, G.A., Elmslie, T., Jolly, E., Hollingworth, G., et al. (1998b). Randomized trial of a portable, self-administered decision aid for postmenopausal women considering long-term preventive hormone therapy. Medical Decision Making, 18, 295-303.
    Ostrander, E.A., & Stanford, J.L. (2000). Genetics of prostate cancer: Too many loci, too few genes. American Journal of Human Genetics, 67, 1367-1375.
    Powe, B.D., & Weinrich, S. (1999). An intervention to decrease cancer fatalism among rural elders. Oncology Nursing Forum, 26, 583-588.
    Powell, I.J., Carpten, J., Dunston, G., Kittles, R., Bennett, J., Hoke, G., et al. (2001). African-American heredity prostate cancer study: A model for genetic research. Journal of the National Medical Association, 93(12, Suppl.), 25S-28S.
    Rebbeck, T.R. (2000). More about: Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. Journal of the National Cancer Institute, 92, 76.
    Royal, C., Baffoe-Bonnie, A., Kittles, R., Powell, I., Bennett, J., Hoke, G., et al. (2000). Recruitment experience in the first phase of the African American Hereditary Prostate Cancer (AAHPC) study. Annals of Epidemiology, 10(8, Suppl.), S68-S77.
    Sacco, E., Prayer-Galetti, T., Pinto, F., Ciaccia, M., Fracalanza, S., Betto, G., et al. (2005). Familial and hereditary prostate cancer by definition in an Italian surgical series: Clinical features and outcome. European Urology, 47, 761-768.
    Schleutker, J., Matikainen, M., Smith, J., Koivisto, P., Baffoe-Bonnie, A., Kainu, T., et al. (2000). A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: Frequent HPCX linkage in families with late-onset disease. Clinical Cancer Research, 6, 4810-4815.
    Smith, R.A., Mettlin, C.J., Davis, K.J., & Eyre, H. (2000). American Cancer Society guidelines for the early detection of cancer. CA: A Cancer Journal for Clinicians, 50, 34-49.
    Stanford, J.L., & Ostrander, E.A. (2001). Familial prostate cancer. Epidemiologic Reviews, 23(1), 19-23.
    Stephan, D.A., Howell, G.R., Teslovich, T.M., Coffey, A.J., Smith, L., Bailey-Wilson, J.E., et al. (2002). Physical and transcript map of the hereditary prostate cancer region at xq27. Genomics, 79(1), 41-50.
    Wang, L., McDonnell, S.K., Elkins, D.A., Slager, S.L., Christensen, E., Marks, A.F., et al. (2001). Role of HPC2/ELAC2 in hereditary prostate cancer. Cancer Research, 61, 6494-6499.
    Weinrich, S., Royal, C., Pettaway, C.A., Dunston, G., Faison-Smith, L., Priest, J.H., et al. (2002). Interest in genetic prostate cancer susceptibility testing among African-American men. Cancer Nursing, 25, 28-34.
    Weinrich, S.P., Faison-Smith, L., Hudson-Priest, J., Royal, C., & Powell, I. (2002). Stability of self-reported family history of prostate cancer among African American men. Journal of Nursing Measurement, 10(1), 39-46.
    Weinrich, S.P., Seger, R., Miller, B.L., Davis, C., Kim, S., Wheeler, C., et al. (2004). Knowledge of the limitations associated with prostate cancer screening among low-income men. Cancer Nursing, 27, 442-453.
    Xu, J. (2000). Combined analysis of hereditary prostate cancer linkage to 1q24-25: Results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics. American Journal of Human Genetics, 66, 945-957.
    Xu, J., Meyers, D., Freije, D., Isaacs, S., Wiley, K., Nusskern, D., et al. (1998). Evidence for a prostate cancer susceptibility locus on the X chromosome. Nature Genetics, 20, 175-179.
    Xu, J., Zheng, S.L., Carpten, J.D., Nupponen, N.N., Robbins, C.M., Mestre, J., et al. (2001). Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer. American Journal of Human Genetics, 68, 901-911.
    Xu, J., Zheng, S.L., Hawkins, G.A., Faith, D.A., Kelly, B., Isaacs, S.D., et al. (2001). Linkage and association studies of prostate cancer susceptibility: Evidence for linkage at 8p22-23. American Journal of Human Genetics, 69, 341-350.
    Zheng, S., Xu, J., Issacs, S.D., Wiley, K., Chang, B., Bleecker, E.R., et al. (2001). Evidence for a prostate cancer linkage to chromosome 20 in 159 hereditary prostate cancer families. Human Genetics, 108, 430-435.